January 24, 2017
Probi praises Nutraceutix purchase, announces good Q4 results
Probi, Swedish bioengineering company that develops probiotics has reported Q4 2016 financial results.
Pharmaceuticals, Biotechnology and Life Sciences
Category: North America
January 24, 2017
Vectura starts with testing asthma drug/device combination for children
Vectura Group is moving on with researching and testing its VR647, a drug/device combination to treat asthma in children for the US market.
January 23, 2017
Swedish Oasmia targets $16B worth US animal health care market
A swedish oncology company Oasmia Pharmaceutical AB, which works on finding cancer cures for animals and humans, said it would move its veterinary assets to the United States.
January 21, 2017
Merck settles to pay $625M to Bristol and Ono for Keytruda, plus royalties for sales
After Bristol-Myers Squibb (Bristol) said on Friday that it won’t ask FDA for faster approval of Opdivo/Yervoy combination for lung cancer, it agreed today with Ono Pharmaceutical to settle all patent-infringement charges related to Merck’s PD-1 antibody Keytruda.
January 20, 2017
J&J expands its medical devices arm, buys private company Megadyne Medical Products
Ethicon Endo-Surgery has bought a private medical device company Megadyne Medical Products, Inc. for an unknown price.
January 20, 2017
Where do you stand against influenza
Flu, or influenza, is a very contagious, acute, viral respiratory infection. Influenza viruses vary in a high degree. The extent…
January 20, 2017
Bristol-Myers not asking for faster Opdivo/Yervov approval for first-line lung cancer in U.S.
Bristol-Myers Squibb said on Thursday that it won’t seek an accelerated approval for the combination of Opdivo plus Yervoy in first-line lung cancer in the U.S.
January 20, 2017
Abzena nets $300 million for its ThioBridge technology
Abzena has made a deal with a San Diego-based biopharmaceutical company for Abzena’s novel site–specific ThioBridge antibody drug conjugate (ADC) linker technology, which links antibodies and other proteins to drugs. The $300 million worth agreement with the…
January 19, 2017
FDA approves Allergan’s skin disease drug
U.S. Food and Drug Administration (FDA) has approved Allergan’s Rhofade skin desease cream, a topical treatment of persistent facial erythema (redness)…
January 19, 2017
Anavex secures cash to study Anavex 2-73 for Rett syndrome
Anavex has ensured most of the cash for a U.S. multicentre Phase 2 clinical trial of Rett syndrome treatment Anavex2-73.